Tekovirimat (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tekovirimat" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

7nih.gov

4^th place

8^th place

3doi.org

2^nd place

5^th place

3europa.eu

68^th place

28^th place

2canada.ca

1,712^th place

2,524^th place

1hres.ca

low place

1nytimes.com

7^th place

37^th place

1fda.gov

447^th place

409^th place

1web.archive.org

1^st place

2^nd place

1sciencenews.org

3,410^th place

3,516^th place

1archive.org

6^th place

9^th place

archive.org

Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, in sod. (Oktober 2005). »An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge«. Journal of Virology. 79 (20): 13139–49. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015.

canada.ca

»Notice: Multiple Additions to the Prescription Drug List (PDL) [2022-01-24]«. Health Canada. 24. januar 2022. Pridobljeno 28. maja 2022.
»New Medicines Approved in 2018«. Health Canada. 15. januar 2020. Pridobljeno 28. maja 2022.

doi.org

Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, in sod. (Julij 2018). »Oral Tecovirimat for the Treatment of Smallpox«. The New England Journal of Medicine. 379 (1): 44–53. doi:10.1056/NEJMoa1705688. PMC 6086581. PMID 29972742.
Damon IK, Damaso CR, McFadden G (Maj 2014). »Are we there yet? The smallpox research agenda using variola virus«. PLOS Pathogens. 10 (5): e1004108. doi:10.1371/journal.ppat.1004108. PMC 4006926. PMID 24789223.
Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, in sod. (Oktober 2005). »An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge«. Journal of Virology. 79 (20): 13139–49. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015.

europa.eu

ema.europa.eu

»Tecovirimat Siga EPAR«. Evropska agencija za zdravila. 10. november 2021. Pridobljeno 23. aprila 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
»Summary of Product Characteristics« (PDF). Evropska agencija za zdravila. Pridobljeno 24. maja 2022.

ec.europa.eu

https://ec.europa.eu/health/documents/community-register/2022/20220106154165/anx_154165_sl.pdf Povzetek glavnih značilnosti zdravila Tecobirimat Siga, vpogled: 7. 6. 2022.

fda.gov

New Drug Therapy Approvals 2018 (PDF). U.S. Food and Drug Administration (FDA) (poročilo). Januar 2019. Pridobljeno 16. septembra 2020.

hres.ca

hpr-rps.hres.ca

»Summary Basis of Decision (SBD) for Tpoxx«. Health Canada. 23. oktober 2014. Pridobljeno 29. maja 2022.

nih.gov

ncbi.nlm.nih.gov

Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, in sod. (Julij 2018). »Oral Tecovirimat for the Treatment of Smallpox«. The New England Journal of Medicine. 379 (1): 44–53. doi:10.1056/NEJMoa1705688. PMC 6086581. PMID 29972742.
Damon IK, Damaso CR, McFadden G (Maj 2014). »Are we there yet? The smallpox research agenda using variola virus«. PLOS Pathogens. 10 (5): e1004108. doi:10.1371/journal.ppat.1004108. PMC 4006926. PMID 24789223.
Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, in sod. (Oktober 2005). »An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge«. Journal of Virology. 79 (20): 13139–49. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015.

pubmed.ncbi.nlm.nih.gov

Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, in sod. (Julij 2018). »Oral Tecovirimat for the Treatment of Smallpox«. The New England Journal of Medicine. 379 (1): 44–53. doi:10.1056/NEJMoa1705688. PMC 6086581. PMID 29972742.
Damon IK, Damaso CR, McFadden G (Maj 2014). »Are we there yet? The smallpox research agenda using variola virus«. PLOS Pathogens. 10 (5): e1004108. doi:10.1371/journal.ppat.1004108. PMC 4006926. PMID 24789223.
Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, in sod. (Oktober 2005). »An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge«. Journal of Virology. 79 (20): 13139–49. doi:10.1128/JVI.79.20.13139-13149.2005. PMC 1235851. PMID 16189015.

dailymed.nlm.nih.gov

»Tpoxx- tecovirimat monohydrate capsule«. DailyMed. 2. december 2021. Pridobljeno 23. aprila 2022.

nytimes.com

McNeil Jr DG (13. julij 2018). »Drug to Treat Smallpox Approved by F.D.A., a Move Against Bioterrorism«. The New York Times. Pridobljeno 16. julija 2018.

sciencenews.org

Cunningham A (13. julij 2018). »FDA approves the first smallpox treatment«. Arhivirano iz prvotnega spletišča dne 12. julija 2018. Pridobljeno 7. junija 2022.

web.archive.org

Cunningham A (13. julij 2018). »FDA approves the first smallpox treatment«. Arhivirano iz prvotnega spletišča dne 12. julija 2018. Pridobljeno 7. junija 2022.